Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 10, 2021Journal of the American Society of NephrologyOpen Access

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDominique BertrandMHM. HamzaouiVLVéronique Lemee

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bertrand et al. (2021) studied this question.

synapsesocial.com/papers/6a98045b161d47660415ee4ahttps://doi.org/10.1681/asn.2021040480
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Is COVID-19 infection more severe in kidney transplant recipients?2020 · 264 citations
  2. 2Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe2020 · 506 citations
  3. 3COVID-19 and Solid Organ Transplantation: A Review Article2020 · 308 citations
  4. 4Impact of COVID-19 in solid organ transplant recipients2020 · 138 citations
  5. 5Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients2021 · 536 citations